Doxjafy AM 400mg/30mg Tablet
By Doxjafy AM
Rx
10 Tablet in a Strip

Composition
Doxofylline(400mg) + Ambroxol(30mg)

Manufacturer - Kiama Lifesciences
Scf. No. 4 Second Floor, Sector 2, Panchkula, Haryana 134112

Expires on or after
October, 2025

liver
For individuals with liver disease, it is important to exercise caution when taking Doxjafy AM 400mg/30mg Tablet. It may be necessary to adjust the dosage of this medication in such cases to ensure safety and effectiveness. Therefore, it is highly recommended to seek advice from your healthcare provider before starting or continuing treatment with Doxjafy AM 400mg/30mg Tablet.

kidney
Caution Doxjafy AM 400mg/30mg Tablet requires caution in severe kidney disease. Dose adjustment may be necessary. Always consult your doctor before use.

alcohol
It is advised to consult your doctor regarding the safety of consuming alcohol with Doxjafy AM 400mg/30mg Tablet.

driving
It is not clear if Doxjafy AM 400mg/30mg Tablet impacts driving. Avoid driving if you have symptoms affecting focus and reaction time.

pregnancy
Doxjafy AM 400mg/30mg Tablet may not be safe to use during pregnancy. Animal studies indicate potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Kindly consult your doctor.

breastfeeding
It is better to consult your doctor before using Doxjafy AM 400mg/30mg Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹87
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024